Silver Book Fact

The excess economic burden of visual impairment and blindess of individuals age 40 and older on the individual, caregivers, and other health care payers is an estimated $5.48 billion annually– $5.12 billion in additional medical care expenditures and $360 million in informal care costs.

Frick, Kevin D., Emily W. Gower, John H. Kempen, and Jennifer L. Wolff. Economic Impact of Visual Impairment and Blindness in the United States. Archives of Ophthalmology. 2007; 125(4): 544-50. http://archopht.ama-assn.org/cgi/content/abstract/125/4/544

Reference

Title
Economic Impact of Visual Impairment and Blindness in the United States
Publication
Archives of Ophthalmology
Publication Date
2007
Authors
Frick, Kevin D., Emily W. Gower, John H. Kempen, and Jennifer L. Wolff
Volume & Issue
Volume 125, Issue 4
Pages
544-50
URL
Read Full Resource

Categories

  • Cost of Disease
  • Economic Burden

Related Facts

  • Prevalence of Age-Related Eye Disease by Gender and Age  
  • The number of cases of early age-related macular degeneration (AMD) is projected to increase from 9.1 million in 2010 to 17.8 million in 2050.  
  • Percent of Blindness in 2010 Due to DR by Region
     
  • Over a 1-year period, 54% of individuals with age-related macular degeneration (AMD) reported a fall and 30% reported more than one.  Of all reported falls, 63% resulted in an injury.  
  • People Affected Worldwide by DR
    By 2030, more than 191 million people around the world will be affected by DR—56 million with vision-threatening DR.